... while UK MHRA releases new safety overview
KeywordsMelanoma Liver Injury Progressive Multifocal Leukoencephalopathy Natalizumab Safety Study
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
- 1.MHRA, CHM.Natalizumab (Tysabri): safety overview - progressive multifocal leukoencephalopathy, hypersensitivity, and hepatotoxicity. Drug Safety Update 1: 2-4, No. 11, Jun 2008Google Scholar
© Adis International limited or Adis Data Information BV 2008